Cargando…
Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy
Background Due to the slow progression of many chronic liver diseases, including hepatitis C, it is not practical or safe to monitor disease progression by serial liver biopsies. Noninvasive laboratory scoring systems based on routine laboratory tests are appealing surrogate markers of liver fibrosi...
Autores principales: | Mada, Pradeep Kumar, Malus, Matthew E, Saldaña Koppel, Daniel Alexander, Adley, Sharon, Moore, Maureen, Alam, Mohammed J, Feldman, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550034/ https://www.ncbi.nlm.nih.gov/pubmed/33062499 http://dx.doi.org/10.7759/cureus.10376 |
Ejemplares similares
-
2222. Impact of Sustained Virologic Response Achieved Through Newer Direct Acting Antivirals in Hepatitis C Infection on Diabetes Mellitus
por: Mada, Pradeep Kumar, et al.
Publicado: (2018) -
Impact of Treatment with Direct Acting Antiviral Drugs on Glycemic Control in Patients with Hepatitis C and Diabetes Mellitus
por: Mada, Pradeep Kumar, et al.
Publicado: (2020) -
Evaluation of Liver Biopsy Findings and Comparison with Noninvasive Fibrosis Scores in Patients with Non-Alcoholic Steatohepatitis
por: Biberci Keskin, Elmas, et al.
Publicado: (2019) -
Assessment of Liver Fibrosis: Noninvasive Means
por: Poynard, Thierry, et al.
Publicado: (2008) -
Role of Percutaneous Liver Biopsy
por: Rodziewicz, Mia, et al.
Publicado: (2012)